89bio, Inc.
ETNBDelisted Oct 30, 2025- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001785173
89bio, Inc. was delisted on Oct 30, 2025; its insiders filed their last Form 4 on Nov 3, 2025; 198 institutions reported holding it in 13F filings for Q3 2025, worth $2.27B in total; no superinvestor held it.
13F holders, Q4 2021
Institutional positions in 89bio, Inc. as of Dec 31, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 50
- +2 vs. Q3 2021
- Shares held
- 17.3M
- −16.8K (−0.1%) vs. Q3 2021
- Total value
- $226.1M
- −$113.3M (−33.4%) vs. Q3 2021
- New holders
- 7
- 13 more added
- Sold out
- 5
- 19 more reduced
Compare with Q3 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ETNB on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 2 | $1.11M |
| Q3 2025 | 198 | $2.27B |
| Q2 2025 | 185 | $1.58B |
| Q1 2025 | 187 | $1.14B |
| Q4 2024 | 156 | $948.7M |
| Q3 2024 | 144 | $773.8M |
| Q2 2024 | 145 | $828.4M |
| Q1 2024 | 150 | $1.14B |
| Q4 2023 | 153 | $1.05B |
| Q3 2023 | 160 | $1.11B |
| Q2 2023 | 157 | $1.46B |
| Q1 2023 | 147 | $1.08B |
| Q4 2022 | 106 | $589.5M |
| Q3 2022 | 86 | $227.3M |
| Q2 2022 | 70 | $104.6M |
| Q1 2022 | 69 | $64.3M |
| Q4 2021 | 50 | $226.1M |
| Q3 2021 | 48 | $339.4M |
| Q2 2021 | 49 | $315.2M |
| Q1 2021 | 67 | $400.6M |
Institutions, Q4 2021
Shares, value and share of portfolio for each institution holding 89bio, Inc.; share changes are against Q3 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Toronto Dominion Bank | 1 | $0 | 0.00% | +1 | New |
| Ameritas Investment Partners, Inc. | 560 | $7.00K | 0.00% | 00.0% | Unchanged |
| Legal & General Group Plc | 820 | $11.0K | 0.00% | 00.0% | Unchanged |
| Aquatic Capital Management LLC | 2,600 | $34.0K | 0.07% | +2,600 | New |
| Tower Research Capital LLC (TRC) | 2,820 | $37.0K | 0.00% | +2,404+577.9% | Added |
| Citigroup Inc | 3,146 | $41.0K | 0.00% | +1,993+172.9% | Added |
| Wells Fargo & Company | 3,652 | $48.0K | 0.00% | +3,652 | New |
| American International Group, Inc. | 5,245 | $69.0K | 0.00% | −90−1.7% | Reduced |
| California State Teachers Retirement System | 5,250 | $69.0K | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 7,276 | $95.0K | 0.00% | +2,921+67.1% | Added |
| New York State Common Retirement Fund | 8,181 | $107.0K | 0.00% | −15−0.2% | Reduced |
| Goldman Sachs Group Inc | 10,245 | $134.0K | 0.00% | +10,245 | New |
| Trexquant Investment LP | 13,408 | $175.0K | 0.01% | +13,408 | New |
| Alliancebernstein L.P. | 14,000 | $183.0K | 0.00% | 00.0% | Unchanged |
| Deutsche Bank AG | 14,340 | $187.0K | 0.00% | −58,004−80.2% | Reduced |
| Glenmede Trust Co NA | 17,929 | $234.0K | 0.00% | 00.0% | Unchanged |
| Bourgeon Capital Management LLC | 20,350 | $266.0K | 0.05% | −1,700−7.7% | Reduced |
| Alps Advisors Inc | 23,469 | $307.0K | 0.00% | −1,144−4.6% | Reduced |
| Charles Schwab Investment Management Inc | 24,809 | $325.0K | 0.00% | 00.0% | Unchanged |
| CSS LLC | 30,045 | $393.0K | 0.02% | +2,100+7.5% | Added |
| Bank of New York Mellon Corp | 31,431 | $411.0K | 0.00% | +772+2.5% | Added |
| Royal Bank of Canada | 35,225 | $460.0K | 0.00% | −62,882−64.1% | Reduced |
| Morgan Stanley | 38,956 | $509.0K | 0.00% | −175,428−81.8% | Reduced |
| Gsa Capital Partners LLP | 45,196 | $591.0K | 0.07% | +17,665+64.2% | Added |
| State of Wisconsin Investment Board | 48,571 | $635.0K | 0.00% | 00.0% | Unchanged |
| Nuveen Asset Management, LLC | 56,140 | $664.0K | 0.00% | −4,152−6.9% | Reduced |
| Two Sigma Investments, LP | 57,655 | $754.0K | 0.00% | −19,401−25.2% | Reduced |
| Two Sigma Advisers, LP | 68,700 | $898.0K | 0.00% | −23,300−25.3% | Reduced |
| Pentwater Capital Management LP | 100,000 | $1.31M | 0.02% | +4,000+4.2% | Added |
| Northern Trust Corp | 102,390 | $1.34M | 0.00% | −882−0.9% | Reduced |
| Bank of America Corp | 106,062 | $1.39M | 0.00% | +90,417+577.9% | Added |
| DAFNA Capital Management LLC | 144,653 | $1.89M | 0.48% | +18,001+14.2% | Added |
| State Street Corp | 146,824 | $1.92M | 0.00% | −579−0.4% | Reduced |
| Altium Capital Management LP | 148,000 | $1.93M | 0.54% | +148,000 | New |
| Orchard Capital Managment, LLC | 150,193 | $1.96M | 0.58% | 00.0% | Unchanged |
| Parkman Healthcare Partners LLC | 152,098 | $1.99M | 0.45% | +6,250+4.3% | Added |
| Geode Capital Management, LLC | 165,001 | $2.16M | 0.00% | −13,324−7.5% | Reduced |
| Pekin Hardy Strauss, Inc. | 182,855 | $2.39M | 0.33% | −2,077−1.1% | Reduced |
| JPMorgan Chase & Co | 186,472 | $2.44M | 0.00% | +65,280+53.9% | Added |
| Citadel Advisors LLC | 270,404 | $3.53M | 0.00% | −19,450−6.7% | Reduced |
| Candriam Luxembourg S.C.A. | 488,197 | $6.38M | 0.04% | 00.0% | Unchanged |
| Vanguard Group Inc | 516,144 | $6.75M | 0.00% | −90,770−15.0% | Reduced |
| FMR LLC | 637,526 | $8.33M | 0.00% | −13,674−2.1% | Reduced |
| Eventide Asset Management, LLC | 716,670 | $9.37M | 0.12% | −420,422−37.0% | Reduced |
| Franklin Resources Inc | 804,420 | $10.5M | 0.00% | −1,619−0.2% | Reduced |
| BlackRock Inc. | 851,741 | $11.1M | 0.00% | +119,347+16.3% | Added |
| Wellington Management Group LLP | 2,150,475 | $28.1M | 0.00% | +454,723+26.8% | Added |
| OrbiMed Advisors LLC | 3,729,442 | $48.7M | 0.63% | 00.0% | Unchanged |
| Ra Capital Management, L.P. | 4,965,769 | $64.9M | 1.14% | 00.0% | Unchanged |
| Federated Hermes, Inc. | 12 | – | – | +12 | New |
| Alyeska Investment Group, L.P. | 0 | $0 | 0.00% | −51,705−100.0% | Sold out |
| Virtus ETF Advisers LLC | 0 | $0 | 0.00% | −10,877−100.0% | Sold out |
| SG Americas Securities, LLC | 0 | $0 | 0.00% | −5,661−100.0% | Sold out |
| Simplex Trading, LLC | 0 | $0 | 0.00% | −3,481−100.0% | Sold out |
| Ellevest, Inc. | 0 | $0 | 0.00% | −3−100.0% | Sold out |